Logo.png
Banzai Announces Reverse Split to Regain NASDAQ Compliance
September 19, 2024 07:43 ET | Banzai International, Inc.
Banzai Announces Reverse Split to Regain NASDAQ Compliance
poet-logo@2018.png
POET and Mitsubishi Electric Collaborate to Develop 3.2T Optical Engines for AI Networks
September 19, 2024 07:35 ET | POET Technologies Inc.
TORONTO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic...
Psyence Biomed logo.png
Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabs
September 19, 2024 07:30 ET | Psyence Biomedical Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has entered into a conditional share sale agreement...
Tigers fans can look forward to the zesty taste of Shock Top beer as a staple in their game day experience.
Shock Top Announces its Official Craft Beer Sponsorship of University of Missouri Athletics
September 19, 2024 07:12 ET | Tilray Brands, Inc.
Shock Top is proud to contribute to the collegiate experience by promoting a culture of inclusivity, support, and pride that transcends the game.
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024 07:00 ET | Lifecore Biomedical, Inc.
Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for...
arqq-logo.png
Arqit Quantum Inc. Announces 25:1 Reverse Share Split
September 19, 2024 07:00 ET | Arqit
LONDON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a leader in quantum safe encryption, today announces that, following approval by the...
Picture1.png
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
September 19, 2024 07:00 ET | Autolus Therapeutics plc
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
Asset 9@3x.png
Nayax to Partner With Five Star's Feeding the Future Charitable Golf Tournament on September 23, 2024
September 19, 2024 07:00 ET | Nayax Ltd.
Nayax is proud to be a sponsor of Feeding the Future’s Golf Classic for the fourth consecutive year.
ACELYRIN, INC. Logo.jpg
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET | ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
FactSet Research Systems Inc.
FactSet Reports Results for Fourth Quarter 2024
September 19, 2024 07:00 ET | FactSet Research Systems Inc.
Q4 GAAP revenues of $562.2 million, up 4.9% from Q4 2023.Organic Q4 ASV plus professional services of $2,272.8 million, up 4.8% year over year.Q4 GAAP operating margin of 22.7%, up approximately 110...